151 related articles for article (PubMed ID: 1711382)
21. Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder.
Volavka J; Czobor P; Sheitman B; Lindenmayer JP; Citrome L; McEvoy JP; Cooper TB; Chakos M; Lieberman JA
Am J Psychiatry; 2002 Feb; 159(2):255-62. PubMed ID: 11823268
[TBL] [Abstract][Full Text] [Related]
22. [Neuroleptics and cognition].
Brunnauer A; Geiger E; Laux G
Psychiatr Prax; 2003 May; 30 Suppl 2():S106-9. PubMed ID: 14509053
[TBL] [Abstract][Full Text] [Related]
23. Clozapine and haloperidol in moderately refractory schizophrenia: a 6-month randomized and double-blind comparison.
Kane JM; Marder SR; Schooler NR; Wirshing WC; Umbricht D; Baker RW; Wirshing DA; Safferman A; Ganguli R; McMeniman M; Borenstein M
Arch Gen Psychiatry; 2001 Oct; 58(10):965-72. PubMed ID: 11576036
[TBL] [Abstract][Full Text] [Related]
24. Clozapine compared with haloperidol for refractory schizophrenia.
Birkett DP
N Engl J Med; 1998 Jan; 338(4):267-8. PubMed ID: 9441246
[No Abstract] [Full Text] [Related]
25. [Atypical pharmacologic characteristics of an antipsychotic drug: clozapine].
Gosselin O; Ribeyre JM; Kahn JP
Encephale; 1997 Sep; 23 Spec No 4():2-6. PubMed ID: 9417400
[TBL] [Abstract][Full Text] [Related]
26. [Creativity and antipsychotic drugs].
Murry P; Torrecuadrada JL
Encephale; 1997 Sep; 23 Spec No 4():17-9. PubMed ID: 9417399
[TBL] [Abstract][Full Text] [Related]
27. Schizophrenia and co-occurring substance use disorder: reward, olfaction and clozapine.
Mesholam-Gately RI; Gibson LE; Seidman LJ; Green AI
Schizophr Res; 2014 May; 155(1-3):45-51. PubMed ID: 24685823
[TBL] [Abstract][Full Text] [Related]
28. Novel pharmacological approaches to the treatment of schizophrenia.
Fink-Jensen A
Dan Med Bull; 2000 Jun; 47(3):151-67. PubMed ID: 10913983
[TBL] [Abstract][Full Text] [Related]
29. [Is there a special indication for fluphenazine in therapy refractory hallucinations?].
Bechter K
Nervenarzt; 1994 Nov; 65(11):798-801. PubMed ID: 7816159
[TBL] [Abstract][Full Text] [Related]
30. Clozapine maintenance therapy in schizophrenia.
Gaszner P; Makkos Z
Prog Neuropsychopharmacol Biol Psychiatry; 2004 May; 28(3):465-9. PubMed ID: 15093952
[TBL] [Abstract][Full Text] [Related]
31. Cognitive deficit in schizophrenia and its neurochemical basis.
Breier A
Br J Psychiatry Suppl; 1999; (37):16-8. PubMed ID: 10211135
[TBL] [Abstract][Full Text] [Related]
32. Pharmacologic treatment of schizophrenia.
Levinson DF
Clin Ther; 1991; 13(3):326-52. PubMed ID: 1683269
[TBL] [Abstract][Full Text] [Related]
33. [Neuroleptic modification of basic schizophrenic disorders].
Heim M; Morgner J
Psychiatr Neurol Med Psychol (Leipz); 1987 May; 39(5):274-80. PubMed ID: 2888144
[TBL] [Abstract][Full Text] [Related]
34. First generation antipsychotics switch with Risperidone in the treatment of chronic schizophrenic patients.
Popović I; Ravanić D; Popović V; Vladejić S; Stanojević A; Stojanović M
Psychiatr Danub; 2011 Dec; 23(4):384-8. PubMed ID: 22075740
[TBL] [Abstract][Full Text] [Related]
35. Neuroleptic-resistant schizophrenia treated with clozapine and ECT.
Benatov R; Sirota P; Megged S
Convuls Ther; 1996 Jun; 12(2):117-21. PubMed ID: 8744173
[TBL] [Abstract][Full Text] [Related]
36. [Clozapine and treatment of negative symptoms].
Lançon C; Farisse J; Llorca PM
Encephale; 1997 Sep; 23 Spec No 4():7-11. PubMed ID: 9417403
[TBL] [Abstract][Full Text] [Related]
37. Effects of clozapine and fluphenazine treatment on responses to m-chlorophenylpiperazine infusions in schizophrenia.
Owen RR; Gutierrez-Esteinou R; Hsiao J; Hadd K; Benkelfat C; Lawlor BA; Murphy DL; Pickar D
Arch Gen Psychiatry; 1993 Aug; 50(8):636-44. PubMed ID: 8343034
[TBL] [Abstract][Full Text] [Related]
38. Norepinephrine and schizophrenia: a new hypothesis for antipsychotic drug action.
Breier A; Elman I; Goldstein DS
Adv Pharmacol; 1998; 42():785-8. PubMed ID: 9328015
[No Abstract] [Full Text] [Related]
39. Effect of clozapine and adjunctive high-dose glycine in treatment-resistant schizophrenia.
Potkin SG; Jin Y; Bunney BG; Costa J; Gulasekaram B
Am J Psychiatry; 1999 Jan; 156(1):145-7. PubMed ID: 9892314
[TBL] [Abstract][Full Text] [Related]
40. A randomized clinical trial of haloperidol decanoate and fluphenazine decanoate in the outpatient treatment of schizophrenia.
Chouinard G; Annable L; Campbell W
J Clin Psychopharmacol; 1989 Aug; 9(4):247-53. PubMed ID: 2570086
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
